CALL FOR PAPERS

Author Information

CERTIFICATE

IMPACT FACTOR 2019

Subject Area

Life Sciences / Biology
Architecture / Building Management
Asian Studies
Business & Management
Chemistry
Computer Science
Economics & Finance
Engineering / Acoustics
Environmental Science
Agricultural Sciences
Pharmaceutical Sciences
General Sciences
Materials Science
Mathematics
Medicine
Nanotechnology & Nanoscience
Nonlinear Science
Chaos & Dynamical Systems
Physics
Social Sciences & Humanities

Why Us? >>

Open Access
Peer Reviewed
Rapid Publication
Life time hosting
Free promotion service
Free indexing service
More citations
Search engine friendly

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

Rhodococcus equi infection in an inmunocompromised patient: how to treat?

Author:

Aceituno Alexandra, M., Vogt Esteban A., Lazo Ana M. and Collado Antonio, R.

Subject Area:

Health Sciences

Abstract:

There are several microorganisms that can cause lung lesions in patients infected by the human immunodeficiency virus (HIV) like Mycobacterium tuberculosis, Pneumocystis carinii or Staphylococcus aureus, among others. Rhodococcusequi is an emergent microorganism associated to opportunistic infections in immunocompromised individuals, especially in patients with Acquired Immune Deficiency Syndrome (AIDS). There is not an established regimen to treat this microorganism, neither the duration of it. This report describes a case of Rhodococcusequi lung infection in a HIV patient.

PDF file:

37907.pdf

DOI: https://doi.org/10.24941/ijcr.37907.02.2020

Announcement

QUICK RESPONSE - CONTACT US

Please feel free to contact me if you have any questions or comments....

Invited for research articles

Call for papers - October 2021

Call for Editorial Board Members

We are seeking professionals to join our Editorial Board. You will be entitled following benefits while...